Literature DB >> 27910188

Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.

Steven J Simmons1, Ryan A Gregg1, Fionya H Tran1, Lili Mo1, Eva von Weltin1, David J Barker2, Taylor A Gentile1, Lucas R Watterson1, Scott M Rawls1, John W Muschamp1.   

Abstract

Abuse of synthetic psychostimulants like synthetic cathinones has risen in recent years. 3,4-Methylenedioxypyrovalerone (MDPV) is one such synthetic cathinone that demonstrates a mechanism of action similar to cocaine. Compared to cocaine, MDPV is more potent at blocking dopamine and norepinephrine reuptake and is readily self-administered by rodents. The present study compared the rewarding and reinforcing properties of MDPV and cocaine using systemic injection dose-response and self-administration models. Fifty kilohertz ultrasonic vocalizations (USVs) were recorded as an index of positive affect throughout experiments. In Experiment 1, MDPV and cocaine dose-dependently elicited 50-kHz USVs upon systemic injection, but MDPV increased USVs at greater rates and with greater persistence relative to cocaine. In Experiment 2, latency to begin MDPV self-administration was shorter than latency to begin cocaine self-administration, and self-administered MDPV elicited greater and more persistent rates of 50-kHz USVs versus cocaine. MDPV-elicited 50-kHz USVs were sustained over the course of drug load-up whereas cocaine-elicited USVs waned following initial infusions. Notably, we observed a robust presence of context-elicited 50-kHz USVs from both MDPV and cocaine self-administering rats. Collectively, these data suggest that MDPV has powerfully rewarding and reinforcing effects relative to cocaine at one-tenth doses. Consistent with prior work, we additionally interpret these data in supporting that MDPV has significant abuse risk based on its potency and subjectively positive effects. Future studies will be needed to better refine therapeutic strategies targeted at reducing the rewarding effects of cathinone analogs in efforts to ultimately reduce abuse liability.
© 2016 Society for the Study of Addiction.

Entities:  

Keywords:  3,4-methylenedioxypyrovalerone; affect; cocaine; self-administration; synthetic cathinone; ultrasonic vocalizations

Mesh:

Substances:

Year:  2016        PMID: 27910188      PMCID: PMC5453848          DOI: 10.1111/adb.12479

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  48 in total

Review 1.  Designer drugs: a medicinal chemistry perspective.

Authors:  F Ivy Carroll; Anita H Lewin; S Wayne Mascarella; Herbert H Seltzman; P Anantha Reddy
Journal:  Ann N Y Acad Sci       Date:  2011-11-17       Impact factor: 5.691

2.  An opponent-process theory of motivation. I. Temporal dynamics of affect.

Authors:  R L Solomon; J D Corbit
Journal:  Psychol Rev       Date:  1974-03       Impact factor: 8.934

3.  Synthesis and GC-MS analysis of a series of homologs and regioisomers of 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Younis F Hamad Abiedalla; Karim Abdel-Hay; Jack DeRuiter; C Randall Clark
Journal:  Forensic Sci Int       Date:  2012-09-17       Impact factor: 2.395

4.  Effect of serotonergic drugs on footshock-induced ultrasonic vocalization in adult male rats.

Authors:  C. Sánchez
Journal:  Behav Pharmacol       Date:  1993-06       Impact factor: 2.293

5.  Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Lucas R Watterson; Peter R Kufahl; Natali E Nemirovsky; Kaveish Sewalia; Megan Grabenauer; Brian F Thomas; Julie A Marusich; Scott Wegner; M Foster Olive
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

6.  Critical involvement of 5-HT2C receptor function in amphetamine-induced 50-kHz ultrasonic vocalizations in rats.

Authors:  Markus Wöhr; Henrike Rippberger; Rainer K W Schwarting; Marcel M van Gaalen
Journal:  Psychopharmacology (Berl)       Date:  2014-11-25       Impact factor: 4.530

7.  Withdrawal from oral cocaine in rate: ultrasonic vocalizations and tactile startle.

Authors:  H M Barros; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

8.  1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.

Authors:  Peter C Meltzer; David Butler; Jeffrey R Deschamps; Bertha K Madras
Journal:  J Med Chem       Date:  2006-02-23       Impact factor: 7.446

9.  Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats.

Authors:  J S Bonano; R A Glennon; L J De Felice; M L Banks; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2013-08-15       Impact factor: 4.530

10.  Involvement of Glutamate NMDA Receptors in the Acute, Long-Term, and Conditioned Effects of Amphetamine on Rat 50 kHz Ultrasonic Vocalizations.

Authors:  Giulia Costa; Micaela Morelli; Nicola Simola
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-19       Impact factor: 5.176

View more
  10 in total

1.  Effects of ceftriaxone on conditioned nicotine reward in rats.

Authors:  Helene L Philogene-Khalid; Steven J Simmons; John W Muschamp; Scott M Rawls
Journal:  Behav Pharmacol       Date:  2017-09       Impact factor: 2.293

2.  Dopamine D1-Like Receptor Agonist and D2-Like Receptor Antagonist (-)-Stepholidine Reduces Reinstatement of Drug-Seeking Behavior for 3,4-Methylenedioxypyrovalerone (MDPV) in Rats.

Authors:  Callum Hicks; Peng Huang; Linnet Ramos; Sunil U Nayak; Yohanka Caro; Allen B Reitz; Garry R Smith; David Y-W Lee; Scott M Rawls; Lee-Yuan Liu-Chen
Journal:  ACS Chem Neurosci       Date:  2018-04-06       Impact factor: 4.418

3.  Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats.

Authors:  Steven J Simmons; Rose Martorana; Helene Philogene-Khalid; Fionya H Tran; Taylor A Gentile; Xinyan Xu; Shu Su; Scott M Rawls; John W Muschamp
Journal:  Psychopharmacology (Berl)       Date:  2017-08-07       Impact factor: 4.530

Review 4.  Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect.

Authors:  Steven J Simmons; Taylor A Gentile
Journal:  Brain Res       Date:  2019-02-20       Impact factor: 3.252

5.  Methylenedioxypyrovalerone (MDPV) impairs working memory and alters patterns of dopamine signaling in mesocorticolimbic substrates.

Authors:  David L Bernstein; Sunyl U Nayak; Chicora F Oliver; Scott M Rawls; Slava Rom
Journal:  Neurosci Res       Date:  2019-07-11       Impact factor: 3.304

6.  Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats.

Authors:  Chicora F Oliver; Steven J Simmons; Sunil U Nayak; Garry R Smith; Allen B Reitz; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2018-03-10       Impact factor: 4.492

7.  Stereoselective Differences between the Reinforcing and Motivational Effects of Cathinone-Derived 4-Methylmethcathinone (Mephedrone) In Self-Administering Rats.

Authors:  Helene L Philogene-Khalid; Steven J Simmons; Sunil Nayak; Rose M Martorana; Shu H Su; Yohanka Caro; Brona Ranieri; Kathryn DiFurio; Lili Mo; Taylor A Gentile; Ali Murad; Allen B Reitz; John W Muschamp; Scott M Rawls
Journal:  ACS Chem Neurosci       Date:  2017-09-22       Impact factor: 4.418

Review 8.  DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants.

Authors:  Steven J Simmons; Jonna M Leyrer-Jackson; Chicora F Oliver; Callum Hicks; John W Muschamp; Scott M Rawls; M Foster Olive
Journal:  ACS Chem Neurosci       Date:  2018-05-11       Impact factor: 4.418

9.  Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats.

Authors:  Samantha J McClenahan; Michael D Hambuchen; Christy M Simecka; Melinda G Gunnell; Michael D Berquist; S Michael Owens
Journal:  Drug Alcohol Depend       Date:  2019-01-04       Impact factor: 4.492

Review 10.  Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications.

Authors:  Arianna Giorgetti; Jennifer P Pascali; Paolo Fais; Guido Pelletti; Andrea Gabbin; Giorgia Franchetti; Giovanni Cecchetto; Guido Viel
Journal:  Life (Basel)       Date:  2021-05-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.